<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Horfield Hc</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Horfield Hc is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0301011B0&amp;denomIds=3.1.1&amp;selectedTab=summary">Bambuterol hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>23</td>
      <td>Selective beta(2)-agonists</td>
      <td>2279</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>14.76</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0301011B0AAAAAA&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Bambuterol 10mg tablets : 23</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=1108020A0&amp;denomIds=11.8.2&amp;selectedTab=summary">Diclofenac sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Ocular diagnostic &amp; peri-operative prepn &amp; photodynamic tt</td>
      <td>6</td>
      <td>0.83</td>
      <td>0.03</td>
      <td>0.13</td>
      <td>6.38</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=1108020A0BBABAC&amp;denomIds=11.8.2&amp;selectedTab=summary" target="_blank">Voltarol Ophtha Multidose 0.1% eye drops : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=1001010AD&amp;denomIds=10.1.1&amp;selectedTab=summary">Ibuprofen lysine</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>9</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>1346</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>6.27</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=1001010ADAAABAB&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Ibuprofen lysine 200mg tablets : 9</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0205052AD&amp;denomIds=2.5.5&amp;selectedTab=summary">Azilsartan medoxomil</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Angiotensin-II receptor antagonists</td>
      <td>1800</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>4.45</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAKXklEQVR4nO2debBlwx3HP4dhLEUitoklaYQJZQtGIkIIKaKHmpmKJIwo68SQWMrWylBlqWiMZcSMEowSY5mUCZJpwSCLJYRRQywjIbrsJLaSMJjR+aP7cXPrvXl3Oee+c975fapO3fvu6dvne9+939N9+vx+3VkIAUEQ6sEyQy1AEITeIYYXhBohhheEGiGGF4QaIYYXhBohhheEGiGGF4QaIYYXhBohhheEGiGGF4QaMTwNn2USLywI/TA8DQ8o47Ybag2CUDYqZ3hlXDbI/o3T0xuVcaN6IEkQKkOlDK+MmwRcNkixQ9LjmcAcZdzIYlUJQnWolOGBw4AJyrh1+9upjFsO2A/AW/0r4EFgxmC9AkGoC5UxfOqqjwSmAkcPUGwvosn7OBlYD/hZseoEoRpUxvDAROA64HJgP2Xcqv2UOQy4su8Pb/Vi4EfAEcq43XqiUhBKTFaFGW9Sl3whsLu3+kVl3FTgFW/1hQ1l1gP+AIz2545dQghZw75NgTuAF4AFwGPp8W/e6kU9/CiCMKRUpYXfDnjVW/1i+nsacFS6Zu/jIOAab/UnzW/2Vj8NbEDsAdybnp8BPCKDekKdGDHUAlqkrzsPQGrl7wd+CMxSxi1DNPwuA1XgrV5C7CUsBGYDKOOmA8cC5xYlXBDKROlbeGXcCGA8cFPTrqnACam7/x1gobf6pTarPx2YrIxbp3ulglB+Sm94opkf9Va/3fiit/px4DXguzQN1rWKt/pNwALn5aBTEEpPFQw/Ebh+gH3nEwNsdgBch/VfAWymjNuxw/cLQmUoteGVcSsBuwFzByhyD7A8cIO3+uNOjpGu7Y8GfqGMW7YjoYJQEUpteGBvYJ63+oP+dnqrA/ADYre8Y7zV9wFPES8NBGHYUnbD/9/ofH94q5/1Vr+Tw7FOBk5Rxn0hh7oEoZSU1vDKuNHAlsRgmsLxVr8MzAAuS7f5BGHYUboftjJuOWWcAX4PHJmusXvFVGAxcIkk3AjDkcINr4zbNrXWrZQdA/wV2BDYxlt9W6HimkhRegcBihiJJwjDisJj6ZVx9xENdC4wvb/QV2XcGsCpwB7AZG/1n7o6aJaFxlj6dlHGrQjcDtzirb6oKy2CUCIKbeGVcWsDawNbA98G7lDGrd+wfx1l3IXAfODfxFa9O7PnQLorsA9wgDLu4KHWIwh5UWgLr4w7DNjUW318uiaeCJxFvI22NbAncClwubf6P7kduMsWvg9l3FrEQcMp3uqbl1IuA7b1Vj/S7TEFoUiKvoYfD9wC8Z65t3oWsDOwI/A48WRwQa5mzxFv9RvA94DzBsqnT2Y/C7hXGXdoL/UJQrsU1sIr41YhBrOoHo+059bC96GM+ypwG7Cft/qhhtcz4Gxi+u7hwN3Aj73VD/ZbkSAMMUW28HsCd/bc7AXgrV4IfB+4QRm3OXxq9p8D2wLjvNUvEOfTmyWz5QplpUjDjwMGvO6tGt7qR4GDgVuVcRvy2TjEuL7Q33QNfyZwkzJu+SETKwgDUIjh04/928Qu7rAh3UE4BngY2BwY3zxFVpotdz5xVh5BKBVFtfC7AA8OlPRSZbzVc4HdgQlLmQ/vBGBTZdxPeqdMEAankEE7ZdwM4IE0Kt97ch606wRl3JrE4J07gNOGw1iGUH1yb+FT4sledD4hxbDAW/0v4FvAF4kBR2u28j5l3CrKuGuVcd8oVKBQS4ro0o8Bnm2ekqqOpEuaQ4BfAw8o47ZfWvl0UrgbeBu4Xhm3QfEqhTqRe5deGXcO8JK3enquFbdDCbr0zaTEoOuBq4k5Be827f8SMUPwAm/1TGXcPsR7/Ds1ly1A2whgCrAI+DvwDPCczNk//CjC8E8BezTMId97Smh4+DRJ6ETi/frZwDRv9UvKuM2AW4ETvdW3NJQ/jhjppxun8EoGPYgY7387cLO3+tUudJ0HrE/MVBwNbAJ8BXgR2Ntb/VandQvFkdZluMZbvX+r78nV8Cki7Vpv9ZjcKu2Ekhq+j7RM1uHAkUSTfR04uDlxKAX3zAAyYHJ6eSwx4GcBcA3pjgFxBt+bgNne6tfb0DIBOIXYk1jUtG8ycCBxxZ//tvkxhQJJC6jMBl72Vh/V6vtyM3waZLoCuNhbfVUulXZKyQ3fRzpDTwCe9FY/sZQyc4EniSG8HwAne6sXNJTJgK2AfYH9gRO81XNaOP5oYg9hV2+1H6DMFGAnYB9v9Yct1LkicBKwOvAG8HrD4wvAa40p0mmQd0vidOO7Ax8CR3irXxnsWHmQ/r+Zt/qjXhwvD9L/eA7wNPG7btnEeRr+CWCSt/qBXCrshooYvlWUcZ8jBvJc562eN0jZDYBZxB/DMQO1zMq4lYG/ACd5q29fSn0ZcCGwLjGXYMDbi+mkfxXxDs3DxNTotdI2CvhyenwXeB54H9ge+AdwV9o2Iy4Q8tMiJ0BJn2sCcA6wIjFXYhZwf39zNpSF9L3dCjxEzOJsy8B5Gn6F0gzyDDPDt0vDINy+wIHe6vlN+zPi5KDPeKsHndkntcIz+az1DU37VyDOEDQWOHSw5CFl3GrE9f1WBR5uPikp4zYBbgD+DJhWehbtoIzbgngC/Qg4jjhWMQ44gDh2MRu4k7gAynt5HrtT0pTtWxAXTbnLW31WJ/VUYvXYtqm54ftIi2tcDXjgTeCttK1BbG3HttqapZPIHGDlVN+7wDvAe8ChwDzg1LyiK9M16jnEEO0ZwCdASBsNzwf7u3nfrsS1Dk4E5vZz8hpFnPp8Z2Ji1PvE3sr89Hk/TNsi4gkja3FbpuF5n6YlaVucPt9IYm+jb1uNeKn2NWAVYkr5b7zVM1v9PzaTm+GzLJsUQvhlLpUVSFV0QnW0VkUnVEdrUTrzDLyZlGNdRVIVnVAdrVXRCdXRWojO0k1TLQhCcYjhBaFG5Gn40l8XJaqiE6qjtSo6oTpaC9E5PEfpBUHoF+nSC0KNGNFO4SzLdga+CbwRQpiZZdkEYCPgWWLo50RiauelxEwvgFNDCD2f/KENrb8l3ncdFUI4tqw6QwgXZ1k2BpgUQji8rDqJAS0G+Bi4qOTf/dXAacR73qeHEN4skc7nARtC2DPLstWJsyh9EEI4s5tjttvC7xBCsEDfZA4bhxDOJ2ZXaaLJRxKDBeYRQyW36kZgF7SkNYTwz1RuqJJDWtKZZdlKxHn0nhsamS1/91sQw3AXD4nKSKtalwCfB5YnBtWURmcIYQHwx/T6LsCVwCtZlnW1nHm7hm++4C/zAEDLWrMsG0+PlqXuh1Z1bk+MSd8xy7L1ipXUL63qHEGMCHsO2KZQRQPTqta1iGG0vyOeTHtNz/3U1qBd6oLsQAzPfJQYnrkRMfnhaWKe99vAdOJqLABThrBb14rWe4DziVlj00KPRzFb1RlCmJbKm9Qq9JQ2v/uzgWWBs0MIhU7e0aXWG4mJOh8BZ4QQetrKD6LzMeASYkLPXcDxxC59RzH0nx5TRukFoT7IKL0g1AgxvCDUCDG8INQIMbwg1AgxvCDUCDG8INQIMbwg1AgxvCDUCDG8INQIMbwg1AgxvCDUiP8B6/oYZdISKlsAAAAASUVORK5CYII="></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0205052ADAAACAC&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Azilsartan medoxomil 80mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0407041B0&amp;denomIds=4.7.4&amp;selectedTab=summary">Almotriptan</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>20</td>
      <td>Treatment of acute migraine</td>
      <td>217</td>
      <td>0.09</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>3.42</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0407041B0AAAAAA&amp;denomIds=4.7.4&amp;selectedTab=summary" target="_blank">Almotriptan 12.5mg tablets : 20</a></div></td></tr></tbody></table>

        <h2>Prescribing where Horfield Hc is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=1501030G0&amp;denomIds=15.1.3&amp;selectedTab=summary">Glycopyrronium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Antimuscarinic drugs</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.82</td>
      <td>0.36</td>
      <td>-2.30</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=1501043A0&amp;denomIds=15.1.4&amp;selectedTab=summary">Alfentanil hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Opioid analgesics</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.82</td>
      <td>0.37</td>
      <td>-2.21</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0406000B0&amp;denomIds=4.6&amp;selectedTab=summary">Betahistine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>42</td>
      <td>Drugs used in nausea and vertigo</td>
      <td>584</td>
      <td>0.07</td>
      <td>0.27</td>
      <td>0.11</td>
      <td>-1.80</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0406000B0AAAAAA&amp;denomIds=4.6&amp;selectedTab=summary" target="_blank">Betahistine 8mg tablets : 18</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0406000B0AAABAB&amp;denomIds=4.6&amp;selectedTab=summary" target="_blank">Betahistine 16mg tablets : 24</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0301020Q0&amp;denomIds=3.1.2&amp;selectedTab=summary">Tiotropium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>105</td>
      <td>Antimuscarinic bronchodilators</td>
      <td>272</td>
      <td>0.39</td>
      <td>0.71</td>
      <td>0.18</td>
      <td>-1.77</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0301020Q0AAACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium brom 2.5microg/dose soln for inhalation CFCfree : 33</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0301020Q0BBACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva Respimat 2.5microg/dose inhalation soln : 43</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0301020Q0BCAAAD&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Braltus 10microgram inhalation pdr caps with Zonda inhaler : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0301020Q0AAAEAE&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 2.5micrograms/dose inhalation soln cart : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0301020Q0AAAAAA&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 18microgram inhalation pdr caps with dev : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0301020Q0AAABAB&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 18microgram inhalation powder capsules : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0301020Q0BBADAE&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva Respimat 2.5microg/dose inhalation soln refill cart : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0&amp;denomIds=1.5.1&amp;selectedTab=summary">Mesalazine (Systemic)</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>110</td>
      <td>Aminosalicylates</td>
      <td>288</td>
      <td>0.38</td>
      <td>0.64</td>
      <td>0.15</td>
      <td>-1.76</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BCAFAT&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 2g modified-release granules sachets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BDADAL&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 2g/59ml enema : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BDAEAK&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g/application foam enema : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BDAGAP&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 500mg gast res MR gran sachets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BDAIAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g suppositories : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BDAJAW&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 500mg gastro-resistant tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0AAAJAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g suppositories : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0AAAKAK&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g/application foam enema : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0AAASAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 800mg gastro-resistant tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BCAAAC&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa Mesalazine 1g/100ml enema : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BDACAB&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 500mg suppositories : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BCACAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 500mg modified-release tablets : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BCADAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g suppositories : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0AAAYAY&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g modified-release tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BCAGAY&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g modified-release tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BBAFAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 800mg MR gastro-resistant tablets : 17</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0AAAIAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg modified-release tablets : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BBAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 400mg MR gastro-resistant tablets : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BHAAAR&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mezavant XL 1200mg tablets : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BIAAAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 800mg MR gastro-resistant tablets : 16</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BIABAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 400mg MR gastro-resistant tablets : 15</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81022&amp;numIds=0105010B0BDAHAU&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1.5g gastro-resistant modified-release gran sachets : 5</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>